Study S001823

Randomized Trial Investigating Exenatide for Diabetes Prevention in Obese, Insulin-Resistant Individuals With Prediabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02084654
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: TRIPLE
Status: COMPLETED
Enrollment: 66
Start: 2007-11
Primary completion: 2012-10
Lead sponsor: Stanford University
Conditions: Pre Diabetes; Insulin Resistance
Interventions: DRUG:Exenatide 5 and 10 mcg 2 times a day; DRUG:placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

First-phase insulin response [7 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.